NASDAQ:ONTX
Onconova Therapeutics Stock News
$1.00
+0 (+0%)
At Close: May 06, 2024
Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)
12:00pm, Friday, 12'th Jun 2020
Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Onconova Therapeutics Filing Shows Board Expects To Withdraw Reverse Stock Split Proposal For Annual Shareholder Meeting
09:42pm, Wednesday, 10'th Jun 2020Noble Financial Keeps a Buy Rating on Dyadic International (DYAI) - Markets
09:18pm, Wednesday, 10'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Dyadic International (DYAI – Research
Onconova Therapeutics Announces Presentation at BIO Digital 2020
12:00pm, Monday, 08'th Jun 2020
NEWTOWN, Pa., June 08, 2020 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to.
3 "Strong Buy" Penny Stocks That Offer Massive Potential Gains
02:11pm, Thursday, 28'th May 2020
The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach is
3 “Strong Buy” Penny Stocks That Offer Massive Potential Gains
01:44pm, Thursday, 28'th May 2020
The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach is Stifel’s Head of Institutional Equity Strategy, Ba
Edited Transcript of ONTX earnings conference call or presentation 14-May-20 8:30pm GMT
03:33pm, Monday, 18'th May 2020
Q1 2020 Onconova Therapeutics Inc Earnings Call
Onconova Therapeutics shares are trading higher after the company reported better-than-expected Q1 EPS results.
12:45pm, Friday, 15'th May 2020Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2020 Results - Earnings Call Transcript
12:33am, Friday, 15'th May 2020
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Avi Oler - Vice President, Corporate Dev
Onconova Therapeutics Q1 EPS $(0.030) Beats $(0.050) Estimate, Sales $52.000K May Not Compare To $150.000K Estimate
08:17pm, Thursday, 14'th May 2020Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
08:05pm, Thursday, 14'th May 2020
NEWTOWN, Pa., May 14, 2020 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to.
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
12:00pm, Monday, 11'th May 2020
Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
